# EDGAR Filing Document

**Accession Number:** 0000101538
**File Stem:** 0001104659-25-110323
**Filing Date:** 2025-11
**Character Count:** 26663
**Document Hash:** bdf0710fe6a828746bf5a91c416c8329
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-110323.hdr.sgml**: 20251112

**ACCESSION NUMBER**: 0001104659-25-110323

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20251112

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251112

**DATE AS OF CHANGE**: 20251112

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UNITED STATES ANTIMONY CORP
- **CENTRAL INDEX KEY:** 0000101538
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRIMARY SMELTING & REFINING OF NONFERROUS METALS [3330]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 810305822
- **STATE OF INCORPORATION:** MT
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-08675
- **FILM NUMBER:** 251472471

**BUSINESS ADDRESS:**
- **STREET 1:** 4438 W LOVERS LANE
- **STREET 2:** UNIT 100
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75209
- **BUSINESS PHONE:** 4068273523

**MAIL ADDRESS:**
- **STREET 1:** 4438 W LOVERS LANE
- **STREET 2:** UNIT 100
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75209

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AGAU MINES INC
- **DATE OF NAME CHANGE:** 19740728

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): November 12, 2025**

---

| |
|:---|
| **UNITED STATES ANTIMONY CORPORATION** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Texas** | **001-08675** | **81-0305822** |
| (State or other jurisdiction<br> of incorporation)  | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

---

| |
|:---|
| **<u>4438 W. Lovers Lane,</u> <u>Unit 100,</u> <u>Dallas,</u> <u>TX</u>** **<u>75209</u>** |
| (Address of principal executive offices and zip code) |

---

**Registrant's telephone number, including area code: (406) 606-4117**

**Former name or former address, if changed since last report: Not Applicable**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

---

| |
|:---|
| Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: |

---

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Common Stock, $0.01 par value** | **UAMY** | **NYSE American** |
| **Common Stock, $0.01 par value** | **UAMY** | **NYSE Texas** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

**Item 2.02 Results of Operations and Financial Condition.**

On November 12, 2025, United States Antimony Corporation ("USAC," "US Antimony Corporation," or the "Company") issued a press release reporting its financial and operational results for the Third Quarter and Nine Months Ended September 30, 2025 ("Press Release"). This Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The foregoing disclosure is qualified in its entirety by the full text of the Press Release.

The information under this Item 2.02, including Exhibit 99.1, of this Current Report on Form 8-K is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.

This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. For a discussion of these risks, please refer to the Company's filings with the Securities and Exchange Commission. The Company disclaims any obligation to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as required by law.

**Item 9.01. Financial Statements and Exhibits.**

**(d)** *Exhibits.*

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [99.1](tm2531023d1_ex99-1.htm) | [Press Release issued by United States Antimony Corporation dated November 12, 2025](tm2531023d1_ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded with the inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **UNITED STATES ANTIMONY CORPORATION** | **UNITED STATES ANTIMONY CORPORATION** |
| Dated: November 12, 2025 | By: | /s/ Richard R. Isaak |
|  |  | Richard R. Isaak |
|  |  | SVP, Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![](tm2531023d1_ex99-1img001.jpg)

**United States Antimony Corporation** 

**Reports Third Quarter and Nine Months Ended**

**September 30, 2025 Financial and Operating Results**

***Revenues Up 182% YOY***

***Gross Profit Up 219% YOY***

 ****

***"The Critical Minerals and ZEO Company"***

***~ Antimony, Cobalt, Tungsten, and Zeolite ~***

 ****

**DALLAS, TX / ACCESS Newswire / November 12, 2025** – United States Antimony Corporation ("USAC," "US Antimony Corporation," or the "Company"), (NYSE American: UAMY) (NYSE Texas: UAMY) reported today its third quarter and nine months ended September 30, 2025 financial and operational results.

Revenues for the first nine months of 2025 increased to $26.23 million, or a 182% increase of $16.92 million, compared to $9.31 million for the first nine months of 2024 . During the same period, cost of revenues increased 170% or $11.96 million. This in-turn allowed the Company's gross profit to more than triple with an increase of 219%, or $4.96 million to $7.22 million as compared to $2.26 million during the same nine-month period in 2024. Gross margin increased to 28% during the first nine months of 2025 from a 24% margin experienced during the same nine months of last year. **This 4% increase in gross margin is before processing any of USAC's in-house antimony recently mined in Montana.** Operating expenses were $11.76 million for the first nine months of 2025, which is an increase of $8.19 million compared to the same period in the prior year.

The Company incurred a net loss of $4.05 million for the nine months ended September 30, 2025, as compared to a net loss of $847k for the corresponding nine-month period in the prior year. Included in the net loss for 2025 was $5.18 million of non-cash expenses, which consisted primarily of $4.69 million of non-cash share-based compensation expense related to management and directors' stock grants that were expensed during this period after shareholder approval at the Company's annual meeting held on July 31, 2025, and $839k of non-cash depreciation and amortization expense.

Our antimony sales were $23.57 million for the first nine months of 2025, which is up $16.5 million, or 235%, over last year. This improvement was primarily due to an increase in the average sales price per pound over the two nine-month reporting periods, not increased volumes.

Our zeolite sales were $2.65 million for the first nine months of 2025, which is up $375k, or 16%, over the same period last year.

The Company's cash position, including its investment in securities (federal bonds), totaled $38.5 million at September 30, 2025, compared to cash only of $18.2 million at year-end 2024. During the first nine months of 2025, USAC dispersed $16.07 million of its cash on capital expenditure additions compared to only $223k during the same period in the prior year. The current year capital expenditure additions included $5.77 million for mineral rights purchases and $9.16 million for engineering, machinery, and construction services to expand the capacity of its existing smelting operations located in Thompson Falls, Montana. Also, during the first nine months of 2025, the Company received i) $20.95 million of net proceeds from the sale of its common stock in "at the market offerings" ii) $17.49 million of net proceeds from the sale of its common stock to one institutional investor and iii) $4.43 million of proceeds from the exercise of pre-existing common stock warrants. Then, subsequent to quarter end, in October 2025, the Company received additional net proceeds of approximately $16 million pursuant to "at the market offerings" and two direct offerings to select institutional investors in the amount of $26 million and $24 million, respectively, for total cash receipts of $66 million.

USAC's current antimony inventory year-to-date has all been acquired from international third-party suppliers and currently sits at record levels. As of September 30, 2025, inventory totaled 230 tons of antimony (both processed and unprocessed). The value of this inventory at today's Rotterdam market price is approximately $9.2 million at September 30, 2025, compared to $2.4 million last year at this time and $3.1 million at the year-end of 2024, both calculated at today's Rotterdam market price.

Today the Company is narrowing its revenue financial guidance for fiscal year 2025 and reiterating its 2026 revenue financial guidance:

**2025 Revenues - $40 - $43 Million**

**2026 Revenues - $125 Million**

Commenting on the Third Quarter and Nine Months Ended September 30, 2025 financial and operational results, Mr. Gary C. Evans, Chairman and CEO of US Antimony Corporation stated, "The third quarter marked a continued improvement in our overall financial performance. We successfully secured two major sales contracts over the last 60 days — a five-year, sole-source IDIQ contract with the U.S. Defense Logistics Agency valued at up to $245 million in September 2025 and a five-year commercial supply agreement with a large U.S. industrial fabric manufacturer valued at approximately $107 million announced yesterday. Both of these contracts provide significant long-term revenue growth and stability for our shareholders. Our success at finding new antimony ore at our recently re-opened mine in Montana, located adjacent to our operating smelter, has been quite significant. Since October 10<sup>th</sup>, we have moved 35 trucks and over 560 tons of antimony ore down the mountain. This new supply will provide significant margin expansion to our operations as compared to the material currently being acquired from international third parties. This should begin to be realized in our financial performance during the first quarter of 2026, as our expansion efforts are completed in January 2026. We continue our efforts to expand our operating base into other critical minerals. We look forward to announcing those increased accomplishments in the near future. As the only fully integrated antimony company in the free world (outside of China and Russia), our mission is to continue becoming the lowest cost producer of antimony products which insures our future viability. We continue down this path and anxiously anticipate future financial results to reflect that accomplishment."

**Conference Call Details**

US Antimony management will host a conference call on Wednesday, November 12, 2025, at 4:15 p.m. Eastern time to discuss its full financial results for the Third Quarter and Nine Months Ended September 30, 2025, followed by a question-and-answer period. The conference call details are as follows:

**Date:** Wednesday, November 12, 2025

**Time:** 4:15 p.m. Eastern time

**Toll-free dial-in Number:** 888-506-0062

**International dial-in number:** 973-528-0011

**Participant Access Code:** 876721

**Webcast URL:** <u>https://www.webcaster5.com/Webcast/Page/2604/53183</u>

The conference call will also be available for replay in the Investors section of the Company's website, along with the transcript, at <u>https://www.usantimony.com/investors</u>.

**About USAC:**

United States Antimony Corporation and its subsidiaries in the U.S., Mexico, and Canada ("USAC," "U.S. Antimony," the "Company," "Our," "Us," or "We") sell antimony, zeolite, and precious metals primarily in the U.S., Mexico, and Canada. The Company mines, purchases, and processes ore primarily into antimony oxide, antimony metal, antimony trisulfide, and precious metals at its facilities located in Montana and Mexico. Antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Antimony metal is used in bearings, storage batteries, and ordnance. Antimony trisulfide is used as a primer in ammunition. The Company also recovers precious metals, primarily gold and silver, at its Montana facility from third party ore. At its Bear River Zeolite ("BRZ") facility located in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, soil amendment and fertilizer, and other miscellaneous applications. Beginning in 2024, the Company began acquiring mining claims, real properties (patented claims) and leases located in Alaska, Montana and Ontario, Canada in an effort to reduce the cost of third-party antimony ore purchases.

Learn more about United States Antimony Corporation at <u>www.usantimony.com</u>.

**Forward-Looking Statements:**

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the Company's future operations, production levels, financial performance, business strategy, market conditions, demand for antimony, zeolite, other critical minerals, and precious metals, expected costs, and other statements that are not historical facts. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which the Company operates, as well as management's beliefs and assumptions. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," "should," "could," and variations of these words or similar expressions are intended to identify such forward-looking statements.

Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in such statements, including, but not limited to: fluctuations in the market prices and demand for antimony and zeolite; changes in domestic and global economic conditions; operational risks inherent in mining and mineral processing; geological or metallurgical conditions; availability and cost of energy, equipment, transportation, and labor; the Company's ability to maintain or obtain permits, licenses, and regulatory approvals; changes in environmental and mining laws or regulations; competitive factors; the impact of geopolitical developments; and the effects of weather, natural disasters, or health pandemics on operations and supply chains. Additional information regarding risk factors that could cause actual results to differ materially is included in the Company's filings with the U.S. Securities and Exchange Commission, including the most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.

The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

---

| | |
|:---|:---|
| **Investor Relations Contact:** | **Media Relations Contact:** |
| Jonathan Miller, VP, Investor Relations | Anthony D. Andora |
| 4438 W. Lovers Lane, Unit 100 | Edge Consulting, Inc. |
| Dallas, Texas 75209 | 1560 Market Street, Ste. 701 |
| E-Mail: <u>Jmiller@usantimony.com</u> | Denver, Colorado 80202 |
| Phone: 406-606-4117 | E-Mail: <u>Anthony@EdgeConsultingSolutions.com</u> |
|  | Phone: 720-317-8927 |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenues | $8701951 | $2572178 | $26227079 | $9307222 |
| Cost of revenues | 6688509 | 2148349 | 19004362 | 7043685 |
| Gross profit | 2013442 | 423829 | 7222717 | 2263537 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative | 882909 | 610888 | 2276455 | 1614048 |
| &nbsp;&nbsp;&nbsp;Salaries and benefits | 4940319 | 429438 | 7305380 | 956402 |
| &nbsp;&nbsp;&nbsp;Professional fees | 522531 | 184402 | 1441436 | 637418 |
| &nbsp;&nbsp;&nbsp;(Gain) loss on sale or disposal of property, plant and equipment | (8216) | (16252) | (8716) | 1242 |
| &nbsp;&nbsp;&nbsp;Gain on lease termination | (469822) |  | (469822) |  |
| &nbsp;&nbsp;&nbsp;Other operating expenses | 1062903 | 106374 | 1217167 | 359894 |
| Total operating expenses | 6930624 | 1314850 | 11761900 | 3569004 |
| Loss from operations | (4917182) | (891021) | (4539183) | (1305467) |
| Other income (expense), net: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest and investment income | 150563 | 157757 | 472719 | 460529 |
| &nbsp;&nbsp;&nbsp;Trademark and licensing income | 7867 | 6553 | 25337 | 21281 |
| &nbsp;&nbsp;&nbsp;Other miscellaneous expense | (21948) | (798) | (11494) | (23828) |
| Total other income, net | 136482 | 163512 | 486562 | 457982 |
| Loss before income taxes | (4780700) | (727509) | (4052621) | (847485) |
| &nbsp;&nbsp;&nbsp;Income tax expense |  |  |  |  |
| Net loss | (4780700) | (727509) | (4052621) | (847485) |
| &nbsp;&nbsp;&nbsp;Preferred dividends | (1875) | (1875) | (5625) | (5625) |
| Net loss available to common shareholders | $(4782575) | $(729384) | $(4058246) | $(853110) |
| Net loss per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $(0.04) | $(0.01) | $(0.03) | $(0.01) |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.04) | $(0.01) | $(0.03) | $(0.01) |
| Weighted average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 123412910 | 108438984 | 118494796 | 108262091 |
| &nbsp;&nbsp;&nbsp;Diluted | 123412910 | 108438984 | 118494796 | 108262091 |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **September 30,**<br>**2025** | **December 31,**<br>**2024** |
| **ASSETS** |  |  |
| CURRENT ASSETS |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $18338679 | $18172120 |
| &nbsp;&nbsp;&nbsp;Investment securities held to maturity | 1270666 |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 1898184 | 1099771 |
| &nbsp;&nbsp;&nbsp;Inventories | 8413161 | 1245724 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 1877249 | 160954 |
| Total current assets | 31797939 | 20678569 |
| Property, plant and equipment, net | 28121338 | 12891447 |
| Operating lease right-of-use assets | 36288 | 565289 |
| Investment securities held to maturity - noncurrent | 18886727 |  |
| Restricted cash for reclamation bonds | 131402 | 98778 |
| IVA receivable and other assets, net | 908647 | 408519 |
| Total assets | $79882341 | $34642602 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| CURRENT LIABILITIES |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $4218043 | $1545708 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities | 1581627 | 1427146 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities - directors | 89530 | 141287 |
| &nbsp;&nbsp;&nbsp;Royalties payable | 207445 | 133434 |
| &nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 28990 | 626562 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | 135754 | 132252 |
| Total current liabilities | 6261389 | 4006389 |
| Operating lease liabilities, net of current portion | 7298 | 129007 |
| Long-term debt, net of current portion | 93167 | 195425 |
| Asset retirement obligations | 1769557 | 1711108 |
| Total liabilities | 8131411 | 6041929 |
| COMMITMENTS AND CONTINGENCIES |  |  |
| STOCKHOLDERS' EQUITY |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock $0.01 par value, 50,000,000 shares authorized: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series A - no shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series B - 750,000 shares issued and outstanding (liquidation preference $980,625 and $975,000, respectively) | 7500 | 7500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series C - 177,904 shares issued and outstanding (liquidation preference $97,847 both periods) | 1779 | 1779 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series D - no shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, $0.01 par value, 250,000,000 shares authorized; 130,338,196 and 112,951,317 shares issued and outstanding, respectively | 1303382 | 1129512 |
| &nbsp;&nbsp;&nbsp;Treasury stock (140,860 and no shares of common stock at cost, respectively) | (510675) |  |
| Additional paid-in capital | 116150588 | 68610905 |
| Accumulated deficit | (45201644) | (41149023) |
| Total stockholders' equity | 71750930 | 28600673 |
| Total liabilities and stockholders' equity | $79882341 | $34642602 |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **Nine months ended September 30,** | **Nine months ended September 30,** |
|  | **2025** | **2024** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| Net loss | $(4052621) | $(847485) |
| Adjustments to reconcile loss to net cash (used in) provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 839353 | 340217 |
| &nbsp;&nbsp;&nbsp;Accretion of asset retirement obligation | 58449 | 54813 |
| &nbsp;&nbsp;&nbsp;Noncash operating lease expense | 289542 | 18611 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 4688772 | 453566 |
| &nbsp;&nbsp;&nbsp;Accretion income from investment securities held to maturity | (222440) |  |
| &nbsp;&nbsp;&nbsp;(Gain) loss on sale or disposal of property, plant and equipment, net | (8716) | 1242 |
| &nbsp;&nbsp;&nbsp;Gain on lease termination | (469822) |  |
| &nbsp;&nbsp;&nbsp;Write-down of inventory to net realizable value |  | 63574 |
| &nbsp;&nbsp;&nbsp;Change in allowance for credit losses | 5798 | (30746) |
| &nbsp;&nbsp;&nbsp;Other noncash items |  | (16107) |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | (804211) | (175748) |
| &nbsp;&nbsp;&nbsp;Inventories | (7167437) | 324264 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (1726295) | (87824) |
| &nbsp;&nbsp;&nbsp;IVA receivable and other assets, net | (500128) | 60856 |
| &nbsp;&nbsp;&nbsp;Accounts payable | 2672335 | 889242 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities | 154481 | 46129 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities – directors | (51757) | 34355 |
| &nbsp;&nbsp;&nbsp;Royalties payable | 74011 | (48255) |
| &nbsp;&nbsp;&nbsp;Stock payable to directors |  | (38542) |
| Net cash (used in) provided by operating activities | (6220686) | 1042162 |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from redemption of certificates of deposit |  | 50641 |
| &nbsp;&nbsp;&nbsp;Purchases of investment securities held to maturity | (19934953) |  |
| &nbsp;&nbsp;&nbsp;Proceeds from sales of property, plant and equipment | 8716 | 314125 |
| &nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (16069244) | (223058) |
| Net cash (used in) provided by investing activities | (35995481) | 141708 |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;Principal payments on long-term debt | (98756) | (71139) |
| &nbsp;&nbsp;&nbsp;Proceeds from exercises of stock options | 55000 |  |
| &nbsp;&nbsp;&nbsp;Treasury stock acquired | (409246) |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock, net of issuance costs | 38440596 |  |
| &nbsp;&nbsp;&nbsp;Proceeds from exercise of warrants | 4427756 |  |
| Net cash provided by (used in) financing activities | 42415350 | (71139) |
| **NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH** | 199183 | 1112731 |
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD | 18270898 | 11954635 |
| **CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD** | $18470081 | $13067366 |
| **SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:** |  |  |
| &nbsp;&nbsp;&nbsp;Interest paid in cash | $14642 | $5630 |
| **NON-CASH FINANCING AND INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;Recognition of operating lease liability and right-of-use asset | $63416 | $787477 |
| &nbsp;&nbsp;&nbsp;Equipment purchased with note payable | $— | $402722 |

---